Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

PRE-REGISTER

Program Chairs

April Armstrong, MD, MPH
Keck School of Medicine, USC
Studio City, California, United States

Last Updated: 10/30/2018 12:00:00 AM

Johann Gudjonsson, MD, PhD
University of Michigan
Ann Arbor, Michigan, United States

Dr. Gudjonsson is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute and an Associate Prof. and Director of Inpatient Consultation and Dermatology at the University of Michigan, Ann Arbor.

Last Updated: 9/18/2018 12:00:00 AM

Nehal Mehta, MD, MSCE, FAHA
National Heart, Lung and Blood Institute
Bethesda, Maryland, United States

Nehal Mehta attended an accelerated seven-year biomedical program where he received his B.A. in 1997 with honors and M.D. in 2001 with Distinction from The George Washington University, and a M.S.C.E. in genetic epidemiology from the University of Pennsylvania in 2009. Following medical school, Dr. Mehta did his internship, residency, and chief medical residency in internal medicine at the University of Pennsylvania Hospital, followed by a fellowship in cardiovascular diseases, nuclear cardiology, and preventive cardiology. Following this, he did a post-doctoral fellowship in genetic epidemiology with a focus on inflammation and lipoproteins at the University of Pennsylvania’s Center for Clinical Epidemiology and Biostatistics (CCEB) and Institute of Translational Medicine and Therapeutics (ITMAT). In 2009, Dr. Mehta joined the faculty in Cardiovascular Medicine at the University of Pennsylvania School of Medicine and at the CCEB as an Associate Scholar. Dr. Mehta came to the NIH in 2012 as the inaugural Lasker Clinical Research Scholar, joining the NHLBI’s Cardiovascular and Pulmonary Branch. In addition to the Lasker Scholarship, Dr. Mehta has received numerous local and national awards and honors, including being named a Fellow of the American College of Physicians and American Heart Association. He is actively involved in several foundations and organizations in membership and leadership capacities including the American Heart Association and National Psoriasis Foundation. He is the editor for the section on cardiovascular, metabolic, and lipoprotein translation in the Journal of Translational Medicine and serves as a reviewers for several international grant organizations as well as biomedical journals.

Last Updated: 1/26/2018 12:00:00 AM

Program Faculty

Hafid Ait-Oufella, MD, PhD
European Georges Pompidou Hospital
Paris, France

Hafid Ait-Oufella completed his PhD in 2008 and both his internship and residency in Cardiology & Intensive Care Medicine in 2007. He was appointed to a tenured position as Associate Professor in 2010 at the Medical School, University Pierre-et-Marie Curie (Paris, France) and was promoted to full professor in 2014. He has been involved in basic, translational and clinical research for the last 15 years continuously at INSERM U689 (Lariboisière hospital, Paris) then at the INSERM U970 PARCC (European Georges Pompidou hospital) since 2009. During the last 15 years, he has trained in vascular biology and atherosclerosis, and acquired expertise in innate and adaptive immunity. Having authored more than 100 scientific papers in peer-reviewed journals, he has been actively studying the cellular and molecular pathways involved in the regulation of the immune-inflammatory response in atherosclerosis and identified a critical role for the regulatory arm of the adaptive T cell response in the control of lesion development, as well as, a previously unsuspected pathogenic role for mature B cells in the development of atherosclerosis and in post-ischemic myocardial remodelling through cooperation between B cells and monocytes.

Last Updated: 1/23/2019 12:00:00 AM

Joel Gelfand, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Dr. Gelfand's research is focused on epidemiology, clinical trials, drug safety, and psoriasis. His epidemiology research focuses on the natural history of psoriasis and the risk of various health outcomes associated with psoriasis such as malignancy, diabetes/metabolic disorders, atherosclerosis/myocardial infarction, and psoriatic arthritis. These studies are examining how the chronic inflammatory nature of psoriasis itself can lead to various health outcomes which share similar immune abnormalities. These studies are important to understanding the impact psoriasis has on a patients health and are informative for planning and interpreting long term safety studies of novel therapies for psoriasis. His clinical trials research focuses on improving efficiency of trials through use of efficient statistical designs and the creation and validation of surrogate endpoints to predict early on in the course of treatment which patients will have a clinical response. He also designs and conducts

Last Updated: 5/30/2013 12:00:00 AM

Marlies Wakkee, MD, PhD
Erasmus MC University Medical Center
Rotterdam, Netherlands

I am based in Rotterdam, the Netherlands, working at the department of dermatology at the Erasmus MC as a dermatologist, mohs surgeon and senior post-doctoral researcher. I have a solid basis in epidemiology with experience in routine, population based and cancer registry data. This has resulted in completing my PhD on ‘Psoriasis, Comorbidities and Treatment’ in 2010. Since then I have continued my research in dermato‐epidemiology being part of the dermato‐epidemiology research group at the Erasmus MC and supervised PhD students in both psoriasis and skin cancer related research. I have a special interest in analyzing and interpreting large medical datasets from varying sources, which become more and more available nowadays due to the digital revolution. What I enjoy about dermato‐epidemiology is the hypothesis generating and testing aspect, which at is best leads to improving patient care.

Last Updated: 2/4/2019 12:00:00 AM

This website uses cookies. Please ensure your cookies are enabled. 
OK